Literature DB >> 23485396

A novel snRNA-like transcript affects amyloidogenesis and cell cycle progression through perturbation of Fe65L1 (APBB2) alternative splicing.

Ilaria Penna1, Irene Vassallo, Mario Nizzari, Debora Russo, Delfina Costa, Paola Menichini, Alessandro Poggi, Claudio Russo, Giorgio Dieci, Tullio Florio, Ranieri Cancedda, Aldo Pagano.   

Abstract

FE65 proteins constitute a family of adaptors which modulates the processing of amyloid precursor protein and the consequent amyloid β production. Thus, they have been involved in the complex and partially unknown cascade of reactions at the base of Alzheimer's disease etiology. However, FE65 and FE65-like proteins may be linked to neurodegeneration through the regulation of cell cycle in post-mitotic neurons. In this work we disclose novel molecular mechanisms by which APBB2 can modulate APP processing. We show that APBB2 mRNA splicing, driven by the over-expression of a novel non-coding RNA named 45A, allow the generation of alternative protein forms endowed with differential effects on Aβ production, cell cycle control, and DNA damage response. 45A overexpression also favors cell transformation and tumorigenesis leading to a marked increase of malignancy of neuroblastoma cells. Therefore, our results highlight a novel regulatory pathway of considerable interest linking APP processing with cell cycle regulation and DNA-surveillance systems, that may represent a molecular mechanism to induce neurodegeneration in post-mitotic neurons.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23485396     DOI: 10.1016/j.bbamcr.2013.02.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Down-regulation of 21A Alu RNA as a tool to boost proliferation maintaining the tissue regeneration potential of progenitor cells.

Authors:  Arianna Gigoni; Delfina Costa; Massimiliano Gaetani; Roberta Tasso; Federico Villa; Tullio Florio; Aldo Pagano
Journal:  Cell Cycle       Date:  2016-08-05       Impact factor: 4.534

2.  Metformin inhibition of neuroblastoma cell proliferation is differently modulated by cell differentiation induced by retinoic acid or overexpression of NDM29 non-coding RNA.

Authors:  Delfina Costa; Arianna Gigoni; Roberto Würth; Ranieri Cancedda; Tullio Florio; Aldo Pagano
Journal:  Cancer Cell Int       Date:  2014-07-02       Impact factor: 5.722

3.  Absence of neurological abnormalities in mice homozygous for the Polr3a G672E hypomyelinating leukodystrophy mutation.

Authors:  Karine Choquet; Sharon Yang; Robyn D Moir; Diane Forget; Roxanne Larivière; Annie Bouchard; Christian Poitras; Nicolas Sgarioto; Marie-Josée Dicaire; Forough Noohi; Timothy E Kennedy; Joseph Rochford; Geneviève Bernard; Martin Teichmann; Benoit Coulombe; Ian M Willis; Claudia L Kleinman; Bernard Brais
Journal:  Mol Brain       Date:  2017-04-13       Impact factor: 4.041

4.  The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells.

Authors:  Ilaria Penna; Arianna Gigoni; Delfina Costa; Serena Vella; Debora Russo; Alessandro Poggi; Federico Villa; Antonella Brizzolara; Claudio Canale; Andrea Mescola; Antonio Daga; Claudio Russo; Mario Nizzari; Tullio Florio; Paola Menichini; Aldo Pagano
Journal:  Oncotarget       Date:  2017-01-31

Review 5.  RNA polymerase III transcription as a disease factor.

Authors:  Meghdad Yeganeh; Nouria Hernandez
Journal:  Genes Dev       Date:  2020-07-01       Impact factor: 11.361

6.  Co-Administration of Fendiline Hydrochloride Enhances Chemotherapeutic Efficacy of Cisplatin in Neuroblastoma Treatment.

Authors:  Antonella Brizzolara; Patrizia Garbati; Serena Vella; Matilde Calderoni; Alessandro Quattrone; Gian Paolo Tonini; Mario Capasso; Luca Longo; Raffaella Barbieri; Tullio Florio; Aldo Pagano
Journal:  Molecules       Date:  2020-11-10       Impact factor: 4.411

Review 7.  Novel ncRNAs transcribed by Pol III and elucidation of their functional relevance by biophysical approaches.

Authors:  Paola Gavazzo; Massimo Vassalli; Delfina Costa; Aldo Pagano
Journal:  Front Cell Neurosci       Date:  2013-11-07       Impact factor: 5.505

8.  Alternative Splicing in Alzheimer's Disease.

Authors:  Julia E Love; Eric J Hayden; Troy T Rohn
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2015-08-15

Review 9.  Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma.

Authors:  Zuozhang Yang; Xiaojuan Li; Yihao Yang; Zewei He; Xin Qu; Ya Zhang
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

Review 10.  Fe65: A Scaffolding Protein of Actin Regulators.

Authors:  Vanessa Augustin; Stefan Kins
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.